Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for pulmonary arterial hypertension within their licensed indications: a systematic review and economic evaluation.
Chen YF, Jowett S, Barton P, Malottki K, Hyde C, Gibbs JS, Pepke-Zaba J, Fry-Smith A, Roberts J, Moore D. Chen YF, et al. Among authors: moore d. Health Technol Assess. 2009 Oct;13(49):1-320. doi: 10.3310/hta13490. Health Technol Assess. 2009. PMID: 19863849 Free article. Review.
Sorafenib for the treatment of advanced hepatocellular carcinoma.
Connock M, Round J, Bayliss S, Tubeuf S, Greenheld W, Moore D. Connock M, et al. Among authors: moore d. Health Technol Assess. 2010 May;14 Suppl 1:17-21. doi: 10.3310/hta14Suppl1/03. Health Technol Assess. 2010. PMID: 20507799 Free article. Review.
Certolizumab pegol (CIMZIA®) for the treatment of rheumatoid arthritis.
Connock M, Tubeuf S, Malottki K, Uthman A, Round J, Bayliss S, Meads C, Moore D. Connock M, et al. Among authors: moore d. Health Technol Assess. 2010 Oct;14(Suppl. 2):1-10. doi: 10.3310/hta14suppl2/01. Health Technol Assess. 2010. PMID: 21047485 Free article. Review.
Protocol for a systematic review of the diagnostic and prognostic utility of tests currently available for the detection of aspirin resistance in patients with established cardiovascular or cerebrovascular disease.
Raichand S, Moore D, Riley RD, Lordkipanidzé M, Dretzke J, O'Donnell J, Jowett S, Bayliss S, Fitzmaurice DA. Raichand S, et al. Among authors: moore d. Syst Rev. 2013 Feb 26;2:16. doi: 10.1186/2046-4053-2-16. Syst Rev. 2013. PMID: 23442317 Free PMC article.
7,114 results